Candriam SCA’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-53,993
| Closed | -$493K | – | 824 |
|
|
2021
Q4 | $493K | Sell |
53,993
-112,923
| -68% | -$1.03M | ﹤0.01% | 748 |
|
|
2021
Q3 | $1.78M | Sell |
166,916
-591,654
| -78% | -$6.32M | 0.01% | 595 |
|
|
2021
Q2 | $11.8M | Sell |
758,570
-531,203
| -41% | -$8.24M | 0.08% | 263 |
|
|
2021
Q1 | $26.2M | Hold |
1,289,773
| – | – | 0.22% | 122 |
|
|
2020
Q4 | $27.3M | Sell |
1,289,773
-29,199
| -2% | -$618K | 0.22% | 123 |
|
|
2020
Q3 | $19.5M | Buy |
1,318,972
+40,000
| +3% | +$593K | 0.18% | 136 |
|
|
2020
Q2 | $18.8M | Buy |
1,278,972
+578,462
| +83% | +$8.51M | 0.2% | 129 |
|
|
2020
Q1 | $16.1M | Hold |
700,510
| – | – | 0.18% | 131 |
|
|
2019
Q4 | $16.5M | Sell |
700,510
-306,090
| -30% | -$7.19M | 0.18% | 131 |
|
|
2019
Q3 | $18.6M | Buy |
1,006,600
+338,000
| +51% | +$6.25M | 0.25% | 82 |
|
|
2019
Q2 | $12.4M | Buy |
668,600
+80,000
| +14% | +$1.48M | 0.15% | 156 |
|
|
2019
Q1 | $14.4M | Buy |
588,600
+125,000
| +27% | +$3.06M | 0.18% | 124 |
|
|
2018
Q4 | $12M | Buy |
463,600
+121,200
| +35% | +$3.14M | 0.18% | 127 |
|
|
2018
Q3 | $10.8M | Buy |
342,400
+273,400
| +396% | +$8.65M | 0.14% | 177 |
|
|
2018
Q2 | $2.68M | Buy |
+69,000
| New | +$2.68M | 0.04% | 421 |
|
|
2016
Q4 | – | Sell |
-60,000
| Closed | -$1.03M | – | 682 |
|
|
2016
Q3 | $1.03M | Buy |
+60,000
| New | +$1.03M | 0.02% | 488 |
|